![]() Pollack C V, Reilly P, Eikelboom J et al. Idarucizumab for reversal of dabigatran prior to acute surgery: a schematic approach based on a case report. Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke. Pollack C V, Reilly P A, Eikelboom J et al. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Graham D J, Reichman M E, Wernecke M et al.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |